These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1901602)

  • 1. Tissue plasminogen activator thrombolysis of a middle cerebral artery embolus in a patient with an arteriovenous malformation. Case report.
    Jafar JJ; Tan WS; Crowell RM
    J Neurosurg; 1991 May; 74(5):808-12. PubMed ID: 1901602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putaminal haemorrhage after recanalization of an embolic MCA occlusion treated with tissue plasminogen activator.
    Brückmann H; Ferbert A
    Neuroradiology; 1989; 31(1):95-7. PubMed ID: 2497402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should thrombolysis be contraindicated in patients with cerebral arteriovenous malformations?
    Sumner CJ; Golden JA; Hemphill JC
    Crit Care Med; 2002 Oct; 30(10):2359-62. PubMed ID: 12394968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial urokinase for treatment of retrograde thrombosis following resection of an arteriovenous malformation. Case report.
    Sipos EP; Kirsch JR; Nauta HJ; Debrun G; Ulatowski JA; Bell WR
    J Neurosurg; 1992 Jun; 76(6):1004-7. PubMed ID: 1588404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic efficacy of a modified tissue-type plasminogen activator, SUN9216, in the rat middle cerebral artery thrombosis model.
    Umemura K; Toshima Y; Nakashima M
    Eur J Pharmacol; 1994 Sep; 262(1-2):27-31. PubMed ID: 7813575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant thrombosed aneurysm associated with an arteriovenous malformation: case report and review of the literature.
    Bapuraj JR; Chandra NE; Suri S
    Australas Radiol; 1997 May; 41(2):176-8. PubMed ID: 9153818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous disappearance of intracranial arterio-venous malformations.
    Pasqualin A; Vivenza C; Rosta L; Scienza R; Da Pian R; Colangeli M
    Acta Neurochir (Wien); 1985; 76(1-2):50-7. PubMed ID: 4003128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.
    Papadopoulos SM; Chandler WF; Salamat MS; Topol EJ; Sackellares JC
    J Neurosurg; 1987 Sep; 67(3):394-8. PubMed ID: 3112328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
    Thomas GR; Thibodeaux H; Bennett WF; Refino CJ; Badillo JM; Errett CJ; Zivin JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):67-73. PubMed ID: 8423552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraventricular thrombolysis for massive intraventricular hemorrhage due to periventricular arteriovenous malformations: no absolute contraindications as rescue therapy prior to surgical repair or embolization?
    Jorens PG; Menovsky TM; Voormolen MH; Van Den Brande E; Parizel PM
    Clin Neurol Neurosurg; 2009 Jul; 111(6):544-50. PubMed ID: 19328624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model.
    Phillips DA; Fisher M; Smith TW; Davis MA
    Ann Neurol; 1988 Apr; 23(4):391-4. PubMed ID: 3132892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular thrombolysis after endovascular treatment of a ruptured arteriovenous malformation.
    Wang A; Ray A; Hu YC
    J Neurointerv Surg; 2017 Feb; 9(2):e8. PubMed ID: 27251552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution of emboli in rats with experimental cerebral thromboembolism by recombinant human tissue plasminogen activator (TD-2061).
    Hara T; Iwamoto M; Ogawa H; Yamamoto A; Tomikawa M
    Thromb Res; 1990 Aug; 59(4):703-12. PubMed ID: 2127865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of middle-cerebral-artery occlusion with alteplase.
    Sakurai J; Egashira T; Yamada Y; Nomura N
    Lancet; 1991 Nov; 338(8776):1206-7. PubMed ID: 1682614
    [No Abstract]   [Full Text] [Related]  

  • 16. Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
    Röttger C; Madlener K; Heil M; Gerriets T; Walberer M; Wessels T; Bachmann G; Kaps M; Stolz E
    Stroke; 2005 Apr; 36(4):841-6. PubMed ID: 15731475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total recanalization of a spontaneously thrombosed arteriovenous malformation. Case report.
    Mizutani T; Tanaka H; Aruga T
    J Neurosurg; 1995 Mar; 82(3):506-8. PubMed ID: 7861234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent embolization during intravenous administration of tissue plasminogen activator in acute cardioembolic stroke. A case report.
    Yasaka M; Yamaguchi T; Yonehara T; Moriyasu H
    Angiology; 1994 Jun; 45(6):481-4. PubMed ID: 8203776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Direct continuous observation of in situ thrombolysis in the cerebral embolic model of rabbits].
    Kashiwabara S; Kurokawa Y; Uede T; Hashi K
    No To Shinkei; 1998 Apr; 50(4):347-54. PubMed ID: 9592824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.